Induction Therapy and Stem Cell Mobilization in Patients with Newly Diagnosed Multiple Myeloma

葉淑婷（2018）。The study of medical resource utilization and clinical outcome in Patient with multiple myeloma〔碩士論文，高雄醫學大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0011-3007201822251000
Byrne, M., Salmasinia, D., Leather, H., Cogle, C. R., Davis, A., Hsu, J. W., Wiggins, L., Chang, M. N., An, Q., Wingard, J. R., & Moreb, J. S. (2014). Tandem Autologous Stem Cell Transplantation for Multiple Myeloma Patients Based on Response to Their First Transplant-A Prospective Phase II Study. Clinical Medicine Insights: Oncology, (), 101-105. https://doi.org/10.4137/CMO.S16835
Puente, P. D. L., Muz, B., Azab, F., Luderer, M., & Azab, A. K. (2014). Molecularly Targeted Therapies in Multiple Myeloma. Leukemia Research and Treatment, (2014), e1-8. https://doi.org/10.1155/2014/976567
董侑淳、劉文雄（2016）。Application of Evidence-Based Medicine in a Patient with Hematopoietic Stem Cell Transplantion。腫瘤護理雜誌，16(1)，15-24。https://doi.org/10.3966/168395442016061601003
Zeng, T., Zhou, L., Xi, H., Fu, W., Du, J., Zhang, C., Jiang, H., & Hou, J. (2015). Multiple Myeloma Patients at Various Cytogenetic Risks Benefit Differently from Autologous Stem Cell Transplantation as a Consolidation Therapy. Stem Cells International, 2015(), 9-15-101. https://doi.org/10.1155/2015/613045